awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42635425-6717C676-3BE3-45B3-83E3-382168CEC8E5
Q42635425-6717C676-3BE3-45B3-83E3-382168CEC8E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42635425-6717C676-3BE3-45B3-83E3-382168CEC8E5
Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease.
P2860
Q42635425-6717C676-3BE3-45B3-83E3-382168CEC8E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42635425-6717C676-3BE3-45B3-83E3-382168CEC8E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d6dc94d2f37450edb18f180c059a7da18cfd4b1f
P2860
Recent advances in antiplatelet agents